Integrated Filing — IndAS
General information about company
| Scrip Code |
544449 |
| NSE Symbol |
ANTHEM |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE0CZ201020 |
| Name of company |
Anthem Biosciences Limited |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2025 |
| Date of end of financial year |
31-03-2026 |
| Date of board meeting when results were approved |
05-02-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
27-01-2026 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Third quarter |
| Nature of report standalone or consolidated |
Standalone |
| Whether results are audited or unaudited for the quarter ended |
Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Unaudited |
| Segment Reporting |
Multi segment |
| Description of single segment |
|
| Start date and time of board meeting |
05-02-2026 11:40:00 |
| End date and time of board meeting |
05-02-2026 12:55:00 |
| Whether cash flow statement is applicable on company |
|
| Type of cash flow statement |
|
| Declaration of unmodified opinion or statement on impact of audit qualification |
Not applicable |
| Whether statement on deviation or variation for proceeds of public issue, rights issue,
preferential issue, qualified institutions placement etc. is applicable to the company for the
current quarter? |
No |
| No. of times funds raised during the quarter |
|
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the
entity? |
No |
| There is no Default on Loans and Debt Securities during this quarter and nine months ended December 31, 2025 |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-10-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
31-12-2025 |
31-12-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Standalone |
Standalone |
| 1 |
Income |
|
Revenue from operations |
41,657.50 |
1,50,681.20 |
|
Other income |
3,992.20 |
12,145.00 |
|
Total income |
45,649.70 |
1,62,826.20 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
18,057.10 |
54,667.80 |
| (b) |
Purchases of stock-in-trade |
0.00 |
0.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
(4,233.30) |
4,843.70 |
| (d) |
Employee benefit expense |
6,547.10 |
19,719.90 |
| (e) |
Finance costs |
112.70 |
496.50 |
| (f) |
Depreciation, depletion and amortisation expense
|
2,674.80 |
7,328.10 |
| (f) |
Other Expenses |
| 1 |
Power and fuel |
1,405.40 |
3,986.80 |
| 2 |
R & M - Plant and machinery |
655.40 |
2,312.40 |
| 3 |
Corporate social responsibility expenses |
1,019.20 |
1,655.10 |
| 4 |
R & D expenses |
517.10 |
1,361.50 |
| 5 |
Legal and professional fees |
168.80 |
299.10 |
| 6 |
Commission expenses |
219.90 |
317.40 |
| 7 |
Pollution control expenses |
129.90 |
531.00 |
| 8 |
Insurance |
141.80 |
468.90 |
| 9 |
Freight and forwarding charges |
123.40 |
367.70 |
| 10 |
Other Expenses |
601.10 |
1,736.90 |
|
Total other expenses |
4,982.00 |
13,036.80 |
|
Total expenses |
28,140.40 |
1,00,092.80 |
| 3 |
Total profit before exceptional items and tax |
17,509.30 |
62,733.40 |
| 4 |
Exceptional items |
(2,498.40) |
(2,498.40) |
| 5 |
Total profit before tax |
15,010.90 |
60,235.00 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
3,778.00 |
15,159.90 |
| 8 |
Deferred tax |
20.50 |
(814.90) |
| 9 |
Total tax expenses |
3,798.50 |
14,345.00 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
11,212.40 |
45,890.00 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
0.00 |
0.00 |
| 16 |
Total profit (loss) for period |
11,212.40 |
45,890.00 |
| 17 |
Other comprehensive income net of taxes |
(73.30) |
(68.20) |
| 18 |
Total Comprehensive Income for the period |
11,139.10 |
45,821.80 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
|
|
|
Total profit or loss, attributable to non-controlling interests |
|
|
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
|
|
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
|
|
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
11,232.20 |
11,232.20 |
|
Face value of equity share capital |
2 |
2 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
|
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
2 |
8.18 |
|
Diluted earnings (loss) per share from continuing operations |
1.98 |
8.09 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
2 |
8.18 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
1.98 |
8.09 |
| 24 |
Debt equity ratio |
0.0200 |
0.0200 |
| 25 |
Debt service coverage ratio |
35.6100 |
43.200 |
| 26 |
Interest service coverage ratio |
122.3300 |
127.3600 |
| 27 |
Disclosure of notes on financial results |
|
Remarks
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-10-2025 |
01-04-2025 |
| Date of end of reporting
period |
31-12-2025 |
31-12-2025 |
| Whether results are audited
or unaudited |
Unaudited |
Unaudited |
| Nature of report standalone or
consolidated |
Standalone |
Standalone |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
| 1 |
CRDMO |
32,680.00 |
1,24,519.80 |
| 2 |
Speciality Ingredients |
8,977.50 |
26,161.30 |
|
Total Segment Revenue |
41,657.50 |
1,50,681.10 |
|
Less: Inter segment revenue |
0.00 |
0.00 |
|
Revenue from operations |
41,657.50 |
1,50,681.10 |
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
| 1 |
CRDMO |
23,258.10 |
78,013.30 |
| 2 |
Speciality Ingredients |
4,575.70 |
13,156.30 |
|
Total Profit before tax |
27,833.80 |
91,169.60 |
|
i. Finance cost |
0.00 |
0.00 |
|
ii. Other Unallocable Expenditure net off Unallocable income |
12,822.80 |
30,934.80 |
|
Profit before tax |
15,011.00 |
60,234.80 |
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
| 1 |
CRDMO |
0.00 |
0.00 |
| 2 |
Speciality Ingredients |
0.00 |
0.00 |
|
Total Segment Asset |
0.00 |
0.00 |
|
Un-allocable Assets |
0.00 |
0.00 |
|
Net Segment Asset |
0.00 |
0.00 |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
| 1 |
CRDMO |
0.00 |
0.00 |
| 2 |
Speciality Ingredients |
0.00 |
0.00 |
|
Total Segment Liabilities |
0.00 |
0.00 |
|
Un-allocable Liabilities |
0.00 |
0.00 |
|
Net Segment Liabilities |
0.00 |
0.00 |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-10-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
31-12-2025 |
31-12-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Standalone |
Standalone |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
Other comprehensive income/(loss) not to be reclassified to profit or loss in subsequent period |
(98.00) |
(91.10) |
|
Total Amount of items that will not be reclassified to profit and loss |
(98.00) |
(91.10) |
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
(24.70) |
(22.90) |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
|
Total Amount of items that will be reclassified to profit and loss |
|
|
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
|
|
| 5 |
Total Other comprehensive income |
(73.30) |
(68.20) |